K99 LM014099/LM/NLM NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2023	3
2024	5

1

Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing.

Miao BY, Sushil M, Xu A, Wang M, Arneson D, Berkley E, Subash M, Vashisht R, Rudrapatna V, Butte AJ. Miao BY, et al. Lancet Digit Health. 2024 Mar;6(3):e222-e229. doi: 10.1016/S2589-7500(23)00244-3. Lancet Digit Health. 2024. PMID: 38395542 Free PMC article. Review.

2

Real-world effectiveness of ustekinumab and vedolizumab in TNF-exposed pediatric patients with ulcerative colitis.

Patel PV, Zhang A, Bhasuran B, Ravindranath VG, Heyman MB, Verstraete SG, Butte AJ, Rosen MJ, Rudrapatna VA; ImproveCareNow Pediatric IBD Learning Health System. Patel PV, et al. J Pediatr Gastroenterol Nutr. 2024 May;78(5):1126-1134. doi: 10.1002/jpn3.12169. Epub 2024 Mar 14. J Pediatr Gastroenterol Nutr. 2024. PMID: 38482890

3

Reducing diagnostic delays in Acute Hepatic Porphyria using electronic health records data and machine learning: a multicenter development and validation study.

Bhasuran B, Schmolly K, Kapoor Y, Jayakumar NL, Doan R, Amin J, Meninger S, Cheng N, Deering R, Anderson K, Beaven SW, Wang B, Rudrapatna VA. Bhasuran B, et al. medRxiv [Preprint]. 2023 Aug 31:2023.08.30.23293130. doi: 10.1101/2023.08.30.23293130. medRxiv. 2023. PMID: 37693437 Free PMC article. Preprint.

4

Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center.

Odufalu FD, Sewell JL, Rudrapatna V, Somsouk M, Mahadevan U. Odufalu FD, et al. Inflamm Bowel Dis. 2024 Jan 5;30(1):29-37. doi: 10.1093/ibd/izad041. Inflamm Bowel Dis. 2024. PMID: 36943305

5

Accurate, Robust, and Scalable Machine Abstraction of Mayo Endoscopic Subscores From Colonoscopy Reports.

Silverman AL, Bhasuran B, Mosenia A, Yasini F, Ramasamy G, Banerjee I, Gupta S, Mardirossian T, Narain R, Sewell J, Butte AJ, Rudrapatna VA. Silverman AL, et al. Inflamm Bowel Dis. 2024 Mar 26:izae068. doi: 10.1093/ibd/izae068. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38533919

6

Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control group.

Rudrapatna VA, Ravindranath VG, Arneson DV, Mosenia A, Butte AJ, Wang S. Rudrapatna VA, et al. BMC Med Res Methodol. 2023 Oct 3;23(1):218. doi: 10.1186/s12874-023-02020-5. BMC Med Res Methodol. 2023. PMID: 37789257 Free PMC article.

7

Personalizing treatment selection in Crohn's disease: a meta-analysis of individual participant data from fifteen randomized controlled trials.

Rudrapatna VA, Ravindranath VG, Arneson DV, Mosenia A, Butte AJ, Wang S. Rudrapatna VA, et al. medRxiv [Preprint]. 2023 Nov 12:2023.11.10.23291837. doi: 10.1101/2023.11.10.23291837. medRxiv. 2023. PMID: 37986977 Free PMC article. Preprint.

8

Algorithmic Identification of Treatment-Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease.

Silverman AL, Sushil M, Bhasuran B, Ludwig D, Buchanan J, Racz R, Parakala M, El-Kamary S, Ahima O, Belov A, Choi L, Billings M, Li Y, Habal N, Liu Q, Tiwari J, Butte AJ, Rudrapatna VA. Silverman AL, et al. Clin Pharmacol Ther. 2024 Jun;115(6):1391-1399. doi: 10.1002/cpt.3226. Epub 2024 Mar 8. Clin Pharmacol Ther. 2024. PMID: 38459719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year